Cargando…
Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
Vitamin K antagonists are being used in the last five decades as an effective anticoagulant. However, for the past few years, new oral anticoagulants (NOACs) have been introduced as newer anticoagulant agents, which are gradually replacing the previously used vitamin K antagonist. Yet, these agents...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077741/ https://www.ncbi.nlm.nih.gov/pubmed/32206471 http://dx.doi.org/10.7759/cureus.7007 |